DEC 23, 2019 9:46 AM PST

Eye Solution Approved for Surgical Application

WRITTEN BY: Nouran Amin

As announced by the Dutch Ophthalmic Research Center in a press release, a new eye solution was recently approved by the US Food and Drug Administration for surgical application. The dye is called Brilliant Blue G ophthalmic solution and is used for staining the internal limiting membrane (ILM) of the eye.

“Brilliant Blue G, intended to stain and distinguish the ILM from the retina to facilitate removal, will be the first FDA-approved product for this indication,” the release said.

Although the Brilliant Blue G (BBG) ophthalmic solution has been in use for staining for internal limiting membrane (ILM) in Europe during the past decade, no commercial formulation was approved by the FDA. Instead, an off-label indocyanine green (ICG) was the common used dye utilized for staining the ILM in the United States.

Studies have addressed differences in visual outcomes that are more improved with the BBG as opposed with the ICG. Furthermore, clinical and library analyses confirmed that there retinal toxicity with ICG use including cell death. In addition, BBG utilizes polyethylene glycol and has a high attachment rate to ILM as opposed to another membrane known as epiretinal membrane (ERM) which allows BBG to function as a negative stain for ERM. The BBG staining and ophthalmic solution also increases ILM rigidity and can aid in ILM peeling with more efficacy and safety and potentially produce better patient outcomes.

Learn more about ILM peeling:

“DORC has always worked closely with surgeons around the world to develop practical advancements in treating eye disorders” Thierry Leclercq, CEO of DORC International, said in the release. “The Brilliant Blue G ophthalmic solution submission is just another example of DORC responding to market needs. We look forward to working with the FDA throughout the review process.”

Source: Healio.com

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 16, 2020
Drug Discovery & Development
JAN 16, 2020
Fatty Acid Supplement Repairs Brain After Stroke in Mice
Researchers have found that supplements containing short chain fatty acids (SCFAs) may be able to help the brain recover from having a stroke. This comes a
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s
FEB 10, 2020
Cancer
FEB 10, 2020
New hope for KRAS-mutant pancreatic cancers
A study published recently in the journal Cancer Research showcases the findings from new research on pancreatic cancer. The study was led by Frank Mc
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
China Approves Trials for Favipiravir to Treat Coronavirus
As of February 25th 2020, there have been 80, 354 reported cases of COVID-19 (Wuhan coronavirus), including 2,707 deaths and 27,898 recoveries. Currently w
MAR 02, 2020
Drug Discovery & Development
MAR 02, 2020
DIY Fecal Transplants Improve Symptoms in 82% of People
Fecal transplants (FMT), the process of putting a healthy person’s fecal matter into another person’s colon, has been approved as a procedure t
MAR 22, 2020
Cancer
MAR 22, 2020
What is "Shotgun ion mobility mass spectrometry sequencing"?
Research published recently in Nature Communications highlights a new method of mapping an essential family of polysaccharides called GAGs (glycosaminoglyc
Loading Comments...